Abstract
Microneedles (MNs) form a safe and non-invasive drug-delivery platform for topic and systemic applications. Biocompatibility, easy application, improved efficiency-controlled release, and low concentrations needed are among the main benefits of the technology. Technologies based on MNs can increase the population's access to cutting-edge therapies through reduced costs and increase the we…